Uncategorised – Page 47 – Market Industry Forecast News

U.S. Patient Engagement Solutions Market: services segment is estimated to expand at the fastest CAGR of 16.8% from 2021 to 2028

U.S. Patient Engagement Solutions Industry Overview

The U.S. patient engagement solutions market size was valued at USD 4.41 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 16.6% from 2021 to 2028. Growing adoption of digital health technologies, supportive government initiatives, the prevalence of chronic diseases, and investments by stakeholders are some of the key growth drivers of this market. The COVID-19 pandemic significantly propelled the market growth. The market players engaged in launching new solutions and features in response to the COVID-19 pandemic while the government and regulatory bodies supported the adoption of these solutions with favorable policies.

For example, in April 2020, the American Medical Association published a 128-page playbook for implementing telehealth during a pandemic. It was intended for practices yet to adopt telehealth but who were looking to make a rapid start. In February 2021, Mytonomy collaborated with the Media & Entertainment Services Alliance to make the new COVID-19 safety and vaccine content available through its platform. In December 2020, GetWellNetwork launched additional GetWell Loop digital care plans to support the COVID-19 vaccine distribution across the U.S.

Gather more insights about the market drivers, restrains and growth of the U.S. Patient Engagement Solutions market

Increasing awareness regarding patient engagement solutions supported by the government organizations such as the Agency of Healthcare Research and Quality and The Office of National Coordinator for Health Information Technology is expected to fuel the market growth. Also, the provision of funds for the implementation of health information exchange systems by the government and non-government organizations along with improved reimbursement policies are anticipated to increase the demand for patient engagement solutions over the forecast period.

In July 2019, IQVIA invested USD 14 million along with other investors in the Series B round, in Belong. Life, a provider of social media app for cancer patients. This is one of the many examples of investments by market players in patient engagement solutions and technologies and is thus expected to contribute to market growth. In November 2018, Force Therapeutics LLC received USD 21 million in investment in a round led by Insight Venture Partners. This supported the company’s plans for national expansion across major health systems, rapid product development, and client acquisition.

Browse through Grand View Research’s Healthcare IT Industry Research Reports.

Infection Surveillance Solutions Market – The global infection surveillance solutions market size was valued at USD 303.7 million in 2017. Increasing prevalence of hospital-acquired infections (HAIs), rising resistance of microbes towards antibiotics, and growing use of automation in healthcare settings are some of the primary trends escalating market growth during the forecast period. However, the high cost of these solutions along with the dearth of skilled healthcare IT professionals can inhibit the growth of the market.

Ophthalmology PACS Market – The global ophthalmology PACS market size was valued at USD 103.14 million in 2017 and is expected to witness a CAGR of 6.5% during the forecast period. Key drivers attributing to the market growth include increasing adoption of teleophthalmology solutions due to lack of skilled ophthalmologists and optometrists. Moreover, significant growth in Information Technology (IT) and its rising impact on the ophthalmology practices are anticipated to drive the market.

U.S. Patient Engagement Solutions Market Segmentation

Grand View Research has segmented the U.S. patient engagement solutions market based on delivery type, component, end use, application, and therapeutic area:

U.S. Patient Engagement Solutions Delivery Type Outlook (Revenue, USD Million, 2016 – 2028)

Web-based
Cloud-based
On-premise

U.S. Patient Engagement Solutions Component Outlook (Revenue, USD Million, 2016 – 2028)

Software
Hardware
Services

U.S. Patient Engagement Solutions End-use Outlook (Revenue, USD Million, 2016 – 2028)

Payers
Providers
Individual users

U.S. Patient Engagement Solutions Application Outlook (Revenue, USD Million, 2016 – 2028)

Social Management
Health Management
Home Healthcare Management
Financial Health Management

U.S. Patient Engagement Solutions Therapeutic Area Outlook (Revenue, USD Million, 2016 – 2028)

Chronic Diseases
Women’s Health
Fitness
Mental Health
Others

Market Share Insights

December 2020: athenahealth released new features for its athenaOne platform-such as scheduling, workflow, documentation, and reporting capabilities-to enable immediate administration of COVID-19 vaccines as and when they become available.

May 2021: IQVIA partnered with Corium, Inc. to deploy its Orchestrated Customer Engagement (OCE) solution to support the commercialization strategy for AZSTARYS-an oral ADHD prodrug.

Key Companies profiled:

Some prominent players in the global U.S. Patient Engagement Solutions market include

Allscripts Healthcare, LLC
Orion Health
Cerner Corporation
McKesson Corporation
athenahealth, Inc.
IBM
Medecision
GetWellNetwork, Inc.
MEDHOST
Lincor
IQVIA
Wolters Kluwer N.V.
Force Therapeutics LLC
Quil
Greenway Health, LLC
Mytonomy
Klara Technologies, Inc.
Solutionreach, Inc.

Order a free sample PDF of the U.S. Patient Engagement Solutions Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

In Situ Hybridization Market: probe-based technology and products is anticipated to boost the growth

In Situ Hybridization Industry Overview

The global in situ hybridization market size was valued at USD 1,333.5 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.9% from 2021 to 2028. Increasing prevalence of target disorders, increasing investments in in-vitro diagnostics space, and technological advancements in in situ hybridization (ISH) are some key driving factors for market growth.

The COVID-19 pandemic also served as a driving factor for the ISH market growth. In June 2021, The University of Oxford collaborated with the University of Warwick to research a method to detect the COVID-19 virus in 20 minutes using in situ hybridization. This technology is previously used to detect pathogens inside cells, such as the Epstein-Barr and HIV. Such developments are expected to propel market growth in the near future.

Gather more insights about the market drivers, restrains and growth of the Global In Situ Hybridization market

In the past few years, various research institutions and organizations have indulged in thorough R&D for developing a technology to determine the molecular profiles of single cells. For instance, Bio-protocol developed in situ hybridization technique known as Proximity Ligation in situ Hybridization. The technique is considered high performance, low cost, rapid multiplexing, and simple to use.

The affordable in situ hybridization technology increases the accessibility for developing countries, which are highly prone to infections and diseases. Regulatory bodies have launched various policies and initiatives to increase awareness among people. For instance, in August 2021, Federal Capital Territory Public Health Department in Nigeria collaborated with the WHO to spread awareness of infectious diseases.

In recent years, the use of ISH products has expanded, leading to an increasing, number of specialized contract research organizations. This intensified the market competition. For instance, with rigorous legislative requirements and high sample throughput, Reveal Biosciences serves research on tissue and advanced tissue technology services using in situ hybridization and other methods.

Browse through Grand View Research’s Biotechnology Industry Research Reports.

Cancer Biomarker Market – The global cancer biomarker market size was valued at USD 10.3 billion in the year 2016 and is estimated to reach a value of USD 33.7 billion by 2025, growing with CAGR of 14.3 %. Growing prevalence of malignancies coupled with increasing focus on development of targeted therapies is a major factor affirming the positive growth of this market.
Pharmaceutical Filtration Market – The global pharmaceutical filtration market size was estimated at USD 13.7 billion in 2016 and is expected to witness lucrative growth during the forecast period. Increasing emphasis on biologics and their development for the treatment of various diseases is a major attribute expected to trigger growth.

In Situ Hybridization Market Segmentation

Grand View Research has segmented the global in situ hybridization market based on technology type, probe, product, application, end-use, and region:

In Situ Hybridization Technology Outlook (Revenue, USD Million, 2017 – 2028)

Fluorescent In Situ Hybridization (FISH)
Chromogenic In Situ Hybridization (CISH)

In Situ Hybridization Probe Type Outlook (Revenue, USD Million, 2017 – 2028)

In Situ Hybridization Product Outlook (Revenue, USD Million, 2017 – 2028)

Instruments
Kits and Probes
Software
Services

In Situ Hybridization Application Outlook (Revenue, USD Million, 2017 – 2028)

Cancer
Cytogenetics
Developmental Biology
Infectious Diseases
Others

In Situ Hybridization End-use Outlook (Revenue, USD Million, 2017 – 2028)

Hospitals & Diagnostic Laboratories
Contract Research Organizations (CROs)
Academic & Research Institutions
Others

In Situ Hybridization Regional Outlook (Revenue, USD Million, 2017 – 2028)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

April 2021: Applied Spectral Imaging and Kromatid signed a strategic partnership agreement to be the exclusive seller of Kromatid’sPinpoint fluorescence in situ hybridization (PPF) probes and assay services.

Key Companies profiled:

Some prominent players in the global In Situ Hybridization market include

Leica Biosystems Nussloch GmbH
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
BIO VIEW
PerkinElmer, Inc.
NeoGenomics Laboratories, Inc.
Bio-Rad Laboratories, Inc.
Oxford Gene Technology
Advanced Cell Diagnostics, Inc.

Order a free sample PDF of the In Situ Hybridization Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Augmented Reality & Virtual Reality In Healthcare Market: North America Dominated The Largest Revenue Share

Augmented Reality & Virtual Reality In Healthcare Industry Overview

The global Augmented Reality & Virtual Reality in healthcare market size was valued at USD 2.0 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 27.2% from 2021 to 2028. Technological advancements and digitalization in healthcare, favorable government initiatives, rising healthcare expenditure, growing usage in surgical procedures, and medical training are some of the fundamental factors anticipated to boost the growth and adoption of the augmented reality (AR) and virtual reality (VR) technologies in the healthcare industry. These technologies have wide applications in healthcare including surgeries, diagnostics, rehabilitation, training, and education.

Augmented and virtual reality techniques are being increasingly adopted in surgeries and diagnostics. Systems such as touch surgery use virtual reality to provide a view of the patient’s anatomy and physiology, thereby providing opportunities for surgeons in the operating room, This, in turn, is expected to augment the growth of the market for augmented reality and virtual reality in healthcare. The growing adoption of Augmented Reality (AR) and Virtual Reality (VR) technologies in medical surgeries to optimize surgical procedures and increase the efficiency of treatment is one of the key factors driving market growth over the past few years. For instance, in December 2019, Augmedics launched the Xvision Spine AR guidance system for spine surgeries in the U.S. This solution allows the surgeon to view the 3D spinal anatomy of the patient during the surgery. Augmedics also received the U.S. FDA approval for Xvision in December 2019. Moreover, the increasing practice of storing medical images and patient data on the AR/VR platform helps in reducing requirements for expensive screens and unnecessary staff.

Gather more insights about the market drivers, restrains and growth of the Global Augmented Reality & Virtual Reality In Healthcare market

Additionally, AR is being widely adopted for education and training purposes for medical personnel. Since AR-based learning modules provide anatomical visualization and simulation it gives the medical personnel a more wholesome complete learning experience. Moreover, these learning modules are even being used to train patients and helps them understand the treatment flow and care management better. AR-based image visualization assists the surgeons and enhancing their accuracy and precision during complex surgeries. For instance, in February 2019 Philips Healthcare collaborated with Azurion and Microsoft to develop a mixed reality concept to provide a 3D holographic AR environment derived from multiple image modalities to assist surgeons.

During the outbreak of the COVID-19 pandemic, AR & VR in healthcare was influenced positively owing to the technological advancements in this space. For instance, in April 2020 XRHealth extended its application by raising USD 7 million to expand its telehealth platform. Similarly, Imperial College and St. Mary’s Hospital in London are using augmented reality glasses to visualize 3D imaging of blood vessels during reconstructive surgeries. Augmented reality and virtual reality in healthcare help in efficiently managing the treatment schedules, treatment delivery, and plans, and thereby it is anticipated to exponentially grow during the pandemic. Additionally, the decreasing costs in healthcare, rapid digitalization of healthcare, and improved delivery of effective health services are expected to drive growth. AR and VR in healthcare are gaining momentum due to widespread adoption in telemedicine, medical training & education, patient care management, medical marketing during the COVID-19 pandemic.

Furthermore, mergers and acquisitions, product development and launches, partnerships, and collaborative agreements are some of the crucial initiatives being undertaken by key players, which are expected to propel market growth. For instance, in January 2021 Hologic Inc acquired Biotheranostics, a molecular diagnostics company for USD 230 million. Through this acquisition, Hologic Inc and Biotheranostics will combine their capabilities and utilize their expertise in oncology diagnostics and advanced woman health diagnostics.

Browse through Grand View Research’s Healthcare IT Industry Research Reports.

Electronic Lab Notebook Market – The global Electronic Lab Notebook (ELN) market size was estimated at USD 532.0 million in 2018 and is anticipated to expand at a CAGR of 4.8% over the forecast period. An increase in demand for automation in laboratories is expected to fuel the adoption of ELN. The benefits such as process optimization, improved regulatory compliance, reduced labor cost, improved data quality, and faster delivery are some of the major factors driving the growth.

Agritourism Market – The global agritourism market is anticipated to grow significantly over the forecast period. Agritourism is associated with rising living standards, economic growth, and socio-cultural enhancement of rural areas. The agritourism market growth is driven by factors such as the strong demand for family-oriented recreational activities provided at an economical cost as compared to other hotel packages. Moreover, the consumer demand for local food and experiences during the farm stay is resulting in increasing stakeholder interest.

Augmented Reality & Virtual Reality In Healthcare Market Segmentation

Grand View Research has segmented the global augmented reality & virtual reality in healthcare market on the basis of component, technology, and region:

AR & VR In Healthcare Component Outlook (Revenue, USD Million, 2016 – 2028)

Hardware
Software
Service

AR & VR In Healthcare Technology Outlook (Revenue, USD Million, 2016 – 2028)

Augmented Reality
Virtual Reality

AR & VR In Healthcare Regional Outlook (Revenue, USD Million, 2016 – 2028)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Key Companies profiled:

Some prominent players in the global Augmented Reality & Virtual Reality In Healthcare market include

CAE
GE Healthcare
Koninklijke Philips N.V.
Intuitive Surgical
Siemens Ltd
Eon Reality, Inc
Layar
Bioflight VR
WorldViz
TheraSim Inc
Mindmaze

Order a free sample PDF of the Augmented Reality & Virtual Reality In Healthcare Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Hospital Information System Market: Patient Engagement Solutions Segment Is Anticipated To Register The Fastest Growth

Hospital Information System Industry Overview

The global hospital information system market size was valued at USD 57.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.9% from 2021 to 2028. Rising government initiatives and increasing demand from hospitals to deploy advanced IT solutions for effective operational efficiency are some of the key factors for the increase in the adoption of hospital information systems (HIS). The increasing need to reduce healthcare expenditure due to hospital workflow inefficiencies is expected to increase hospital information systems implementation worldwide. Thus, the growing demand for reduced healthcare costs and effective clinical outcomes is one of the key factors responsible for the adoption of information systems in developed economies and also in emerging economies, such as India, China, the Philippines, and Brazil.

Developing and developed regions are struggling to achieve high care delivery standards, which are both cost-effective and quality-oriented with minimum medical errors. With the help of HIS, providers are now able to streamline their workflows by offering enhanced patient outcomes about costs through investigational mining of electronic patient records for identifying inherent medical inaccuracies in the system. It enables them to offer cost-effective services to patients while reducing resources wastage. Moreover, increasing penetration of technologically advanced hospital management solutions is also aiding the market growth.

Gather more insights about the market drivers, restrains and growth of the Global Hospital Information System market

The increased implementation of healthcare IT solutions and services by hospitals to provide enhanced patient care at reduced expenses, coupled with the growing need to upgrade already existing information systems, is likely to be a key driving factor. Moreover, consistent upgrades in healthcare and IT infrastructures along with increased adoption of cloud computing in hospital settings are also contributing significantly to the market growth. Since, healthcare data is subject to stringent regulatory oversight to ensure patient confidentiality, safe and secure storage, user-level authorization, traceability of information, and mitigation of other cybersecurity threats. Thus, hospitals are switching from on-premises deployments to cloud-based information systems to maintain high data security and avoid security breaches.

In addition, the growing adoption of EHR systems among developing economies owing to increased utilization of electronic health records for patient-centric care is expected to significantly boost the market growth over the next few years. EHR emerged as one of the key potential segments in hospital information systems, primarily owing to the rising demand for streamlining electronic healthcare solutions, technological advancements in healthcare information IT, and growing demand for EHR-integrated tools. Also, government initiatives promoting EHR are likely to propel the demand for electronic systems. EHRs offer a range of advantages to hospitals and patients, ultimately leading to increased system productivity and patient satisfaction.

Furthermore, associated benefits with these information systems, such as operational cost-reduction minimized errors in the end-use facility, and increased successful operational outcomes, are expected to propel market growth. Moreover, government initiatives supporting eHealth programs in developed as well as developing regions and incentives promoting information systems implementation in hospital settings in certain countries are further expected to drive the market over the forecast period.

Browse through Grand View Research’s Healthcare IT Industry Research Reports.

Patient Safety And Risk Management Software Market – The global patient safety and risk management software market size was valued at USD 1.3 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 11.0% from 2020 to 2027. An increase in the number of medical errors coupled with an increased necessity to provide patient safety and care are the key factors driving the market. Also, the increased adoption of digitization and multiple initiatives taken up by the government to promote the healthcare software market is further accelerating the growth of the market.

Hospital Outsourcing Market – The global hospital outsourcing market size was valued at USD 270.9 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 10.4% from 2020 to 2027. Hospitals are increasingly outsourcing internal activities to third-party service providers such as medical billing and IT services. The hospitals are mainly outsourcing medical billing and IT services to third-party service providers due to a lack of expertise and the unavailability of skilled resources in the industry.

Hospital Information System Market Segmentation

Grand View Research, Inc. has segmented the global hospital information system market report on the basis of type, deployment, component, and region:

Hospital Information System Type Outlook (Revenue, USD Million, 2016 – 2028)

Electronic health record
Electronic medical record
Real-time healthcare
Patient engagement solution
Population health management

Hospital Information System Deployment Outlook (Revenue, USD Million, 2016 – 2028)

Web-based
On-premises
Cloud-based

Hospital Information System Component Outlook (Revenue, USD Million, 2016 – 2028)

Software
Hardware
Services

Hospital Information System Regional Outlook (Revenue, USD Million, 2016 – 2028)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

January 2019: Cerner Corporation collaborated with CoverMyMeds to integrate patient-specific information into the EHR for healthcare providers to view pricing information at point-of-care.

Key Companies profiled:

Some prominent players in the global Hospital Information System market include

Carestream Health
Siemens Healthineers
McKesson Corporation
Philips Healthcare
Merge Healthcare Inc. (IBM)
GE Healthcare
Cerner Corporation
Allscripts
NextGen Healthcare

Order a free sample PDF of the Hospital Information System Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Microrna Market Is Expected To Expand At A CAGR Of 19.8% From 2021 To 2028

microRNA Industry Overview

The global microRNA market size was valued at USD 854.6 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 19.8% from 2021 to 2028. Key trends that have collectively contributed to market growth over the years include emerging microRNA (miRNA) tools for disease-associated analytical applications, immense traction gained by miRNA target prediction and identification, and persisting wide adoption of the majority of the miRNA tools. Additionally, miRNAs are amongst the most important potential biopharmaceutical candidates that are entering in commercial space for developing potential future medicines.

Biopharmaceutical companies are increasingly engaging in the search for new therapeutic molecules that can act as new drugs which is further driving the market for microRNA. There are several miRNA-based candidates that are under clinical trials such as anti-miR compounds and specific inhibitors for miRNAs which can act as potential therapeutic solutions. Hence, RNA therapeutics is considered a trending investing area that will lead to the development of profitable drugs.

Gather more insights about the market drivers, restrains and growth of the Global microRNA market

Increasing adoption of microRNA as a biomarker is driving the market. The miRNA biomarkers are of particular focus on genome-wide studies, and data-driven methodology, as they demonstrate high reproducibility and robustness when compared to traditional methods. Hence, they serve as promising candidates for the development of biomarkers. Moreover, the growing interest in liquid biopsies has further led to the increasing importance of miRNAs for biomarker discovery and development.

A steep increase in the research activities exploring the potential of miRNA biomarkers across prognosis, diagnosis, and therapeutics is expected to favor the market expansion in the near future. For instance, in January 2020, researchers explored the possibility of miRNA found in peripheral blood as a biomarker for diagnosing Bipolar II disorder (BD-II) using next-generation sequencing. miRNAs can be a possible noninvasive solution for the diagnosis of other neurodegenerative disorders.

In addition, the technological innovation for improving the sensitivity and selectivity of miRNA detection is further contributing to the growth of the market for microRNA. The newly developed methods for miRNA detection include nanoparticle-based amplification, RCA-based methods, DSN-based methods, LAMP-based methods, and enzyme-free amplification. Similarly, in January 2020, researchers developed a program-based isothermal amplification technique for specific and quantitative digital measurement of miRNA. The advantage of the system is that contamination is reduced by the fact that this system is dependent on the signal amplification process rather than direct replication of the targeted sequence, as it is done using PCR-based approaches.

Browse through Grand View Research’s Biotechnology Industry Research Reports.

Healthcare Specialty Enzymes Market – The global healthcare specialty enzymes market size was valued at USD 2.4 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 6.2% from 2020 to 2027. The rising prevalence of diseases associated with metabolism has been witnessed in recent years wherein an appropriate understanding of enzyme abnormality has led to the increasing use of enzymes as disease markers in clinical examinations.
DNA Sequencing Market – The global DNA sequencing market size was valued at USD 4.7 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 11.4% from 2020 to 2027. Rapid advancements in sequencing technology and bioinformatics have enabled the identification of DNA variations. These advancements also determine variants associated with increased risk for disease.

microRNA Market Segmentation

Grand View Research has segmented the global microRNA market on the basis of products, services, application, end-use, and region:

microRNA Products Outlook (Revenue, USD Million, 2017 – 2028)

Instruments
Consumables

microRNA Services Outlook (Revenue, USD Million, 2017 – 2028)

Service Type
By Specimen

microRNA Application Outlook (Revenue, USD Million, 2017 – 2028)

Cancer
Infectious Diseases
Immunological Disorder
Cardiovascular Disease
Neurological Disease
Others

microRNA End-use Outlook (Revenue, USD Million, 2017 – 2028)

Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Other end-users

microRNA Regional Outlook (Revenue, USD Million, 2017 – 2028)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

July 2020: Sistemic Ltd announced the expansion of its patent covering for the use of microRNAs as predictive analytes for cellular function.

Key Companies profiled:

Some prominent players in the global microRNA market include

Merck KGaA
Thermo Fisher Scientific, Inc.
Horizon Discovery Ltd.
Synlogic
QIAGEN
GeneCopoeia, Inc.
New England Biolabs
Quantabio
NanoString
BioGenex
SeqMatic LLC
Miltenyi Biotec
Sistemic Scotland Limited
Biodynamics Laboratory Inc.
OriGene Technologies, Inc.

Order a free sample PDF of the microRNA Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Pneumatic Nebulizers Market Is Expected To Grow At A Compound Annual Growth Rate (CAGR) Of 6.0%

Pneumatic Nebulizers Industry Overview

The global pneumatic nebulizers market size was valued at USD 644.34 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.0% over the forecast period. The increasing incidence of chronic respiratory diseases, demand for home healthcare devices, and growing geriatric population are the factors expected to drive the market. According to statistics published by the CDC, approximately 18.4 million adults in the U.S. suffer from asthma. The COVID-19 pandemic has impacted all industries, including the pneumatic nebulizers market. Asthma or COPD patients, who were aware of the risk of airborne transmission of COVID-19, were hesitant about the use of inhaled medications, which are considered as a potential source of viral transmission and immunosuppression.

Gather more insights about the market drivers, restrains and growth of the Global Pneumatic Nebulizers market

However, medical practitioners advised all such patients to continue using their prescribed inhaled medications, including nebulizers. Therefore, the overall impact of COVID-19 on the market was minimal. Easy availability of compact pneumatic nebulizers ideal for home use, and technological innovations in these devices to reduce the sound created by them & improve their functionality, are increasing their adoption in-home healthcare. Moreover, these devices are favored by third-party payers, such as insurance companies, as they aim to reduce costs while providing quality healthcare services. These factors are expected to boost the adoption over the forecast period.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

Hyaluronic Acid Raw Material Market – The global hyaluronic acid raw material market size was valued at USD 4.30 billion in 2015 and is expected to grow at a CAGR of 6.7% over the forecast period, to reach an estimated value of USD 7.25 billion by 2024. The market is anticipated to boom due to the enlarging aging population and the introduction of technologically advanced products enabling localized drug delivery. In addition, the growing number of aesthetic procedures in various countries, such as the U.S., Brazil, China, Japan, and South Korea, is one of the crucial factors anticipated to boost the market over the coming few years.

Reprocessed Medical Devices Market – The global reprocessed medical devices market size was estimated at USD 1.64 billion in 2016 and is anticipated to grow at a CAGR of 20.6% over the forecast period. Rising clinical urgency to reduce the generation of medical waste in hospitals and other healthcare settings is a significant growth driver of the market.

Pneumatic Nebulizers Market Segmentation

Grand View Research has segmented the global pneumatic nebulizers market on the basis of the product, end-use, and region:

Pneumatic Nebulizers Product Outlook (Revenue, USD Million, 2016 – 2028)

Breath-actuated
Vented

Pneumatic Nebulizers End-use Outlook (Revenue, USD Million, 2016 – 2028)

Hospitals & Clinics
Home Healthcare

Pneumatic Nebulizers Regional Outlook (Revenue, USD Million, 2016 – 2028)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

January 2020, OMRON Corp. announced the opening of the Automation Center Tokyo (ATC-TOKYO) in Tokyo. With this center, customers can join the company to find solutions for any challenges arising during production.

Key Companies profiled:

Some prominent players in the global Pneumatic Nebulizers market include

Koninklijke Philips N.V.
Omron Corp.
PARI Pharma
General Electric Company
Allied Healthcare Products, Inc.
BD (Becton, Dickinson & Company)
GF Health Products, Inc.
Medline Industries, Inc.
Briggs Healthcare
Vectura Group Plc

Order a free sample PDF of the Pneumatic Nebulizers Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Nephrology And Urology Devices Market Is Expected To Grow At A CAGR Of 6.6% From 2021 To 2028

Nephrology And Urology Devices Industry Overview

The global nephrology and urology devices market size was valued at USD 4.34 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.6% from 2021 to 2028. The high incidence and prevalence of Chronic Kidney Disease (CKD) coupled with rising elderly population is the major factor driving the market growth. According to the estimates of the National Kidney Foundation, 10.0% of the worldwide population is affected by CKD. Thus, the increasing target population is boosting the overall product demand. Rising incidences of diabetes and high blood pressure (hypertension) globally are also contributing to the growth of the market as these two diseases are primary reasons for kidney failure. As per the data published by the American Kidney Fund, 38.4% of kidney failures are caused due to diabetes, and 25% due to high blood pressure.

This high correlation between kidney failure and aforementioned disorders is expected to accentuate the demand for urology & nephrology devices. Moreover, the cases of diabetes and hypertension are increasing in developing countries of Asia Pacific (APAC) & Middle East and North Africa (MENA) regions, owing to changes in lifestyle and rising geriatric population. For instance, as per the International Diabetes Federation, in 2019, the number of diabetes cases in the IDF MENA region was 55 million, which is estimated to reach 108 million by 2045. These factors are expected to increase product use and demand during the forecast period.

Gather more insights about the market drivers, restrains and growth of the Global Nephrology And Urology Devices market

In addition, the market is expected to be driven by the increasing geriatric population, which is highly susceptible to various diseases including kidney and urinary disorders. As per the WHO, the number of people aged 65 years and above is expected to rise from 7% in 2000 to 16% in 2050, globally. Old age is considered one of the greatest risk factors for developing various medical conditions. Aging also weakens the immune system and consequently increases a patient’s susceptibility to various ailments, such as renal disorders, diabetes, prostate cancer, and urinary retention. According to the American Society of Nephrology, urologic diseases are the third-most common concern among the geriatric population, and these account for approximately 47% of physician visits.

Furthermore, the growing demand for minimally invasive procedures due to the recent technological innovations is expected to increase product sales. Devices, such as ureteral stents, catheters, guidewires, & renal dilators, are developed using advanced materials including nitinol, polyurethanes/polycarbonates, and silicone. Carbothane is a material resistant to several chemicals, such as iodine, hydrogen peroxide, or alcohol, which increases its life. For instance, MAHURKAR Chronic Carbothane catheter, developed by Medtronic plc is made of Carbothane, which provides superior kink resistance and enables simple single insertion, while facilitating high flow rates with low arterial & vein pressure. Thus, the usage of advanced materials in product manufacturing for enhanced strength and resistance increases the demand, thereby driving the market growth.

Countries, such as U.S. and Canada, have witnessed a high prevalence rate of chronic kidney and urinary disorders owing to sedentary lifestyles. In addition, the increasing number of patients undergoing surgeries and rising consumer awareness about minimally invasive surgeries are also contributing to the market growth in these countries. In addition, as per the Population Reference Bureau fact sheet, the number of people in the U.S. aged 65 years and above is expected to nearly double from 52 million in 2018 to 95 million by 2060 (rise from 16% to 23%). This will support the market growth. Similarly, according to the Canadian Institute for Health Information’s (CIHI) report Canadian Organ Replacement Register (CORR), 2019, the number of people in Manitoba, a Canadian Province, on dialysis has increased by 57% from 2009 to 2019.

Moreover, due to the global pandemic, healthcare facilities, such as hospitals, have been exhausted with a large influx of such patients; therefore, many countries have postponed elective surgeries and other healthcare procedures for an indefinite period. Moreover, the demand for renal disease treatment products used in homecare has increased. Similarly, the demand for home healthcare among the aging population is also increasing as they are at a higher risk of acquiring the infection and cannot visit any healthcare facility. Home health service providers are offering multiple home care services, including the delivery of medicines. This is likely to boost the growth of nephrology and urology devices market during the forecast period.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

Electric Bed Market – The global electric bed market size was valued at USD 2.40 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.8% from 2021 to 2027. The increasing demand for electric bed is attributed to the rising number of hospitals in developing countries, increasing patient population, growing geriatric population, and rising adoption of technologically advanced products. The recent outbreak of COVID-19 across the globe has increased the number of patient admissions in hospitals and clinics.
Medical Equipment Maintenance Market – The global medical equipment maintenance market size was valued at USD 35.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.9% from 2021 to 2027. Growing global demand for medical devices, rising prevalence of life-threatening diseases leading to higher diagnostic rates, and rising demand for the refurbished medical equipment are expected to drive the market for medical device maintenance during the forecast period. Currently, several medical devices such as syringe pumps, electrocardiographs, X-ray units, centrifuge, ventilator units, ultrasound, and autoclave are available in the healthcare industry.

Nephrology And Urology Devices Market Segmentation

Grand View Research has segmented the global nephrology and urology devices market on the basis of product and region:

Nephrology & Urology Devices Product Outlook (Revenue, USD Million, 2016 – 2028)

Ureteral Catheters
PCN Catheters
Urinary Stents
Stone Basket
Urology Guidewires
Renal Dilators
Others

Nephrology & Urology Devices Regional Outlook (Revenue, USD Million, 2016 – 2028)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

February 2019: Coloplast signed a three-year agreement with Premier, Inc., a U.S.-based healthcare improvement company, for its urology products.

Key Companies profiled:

Some prominent players in the global Nephrology And Urology Devices market include

Medtronic plc
Fresenius Medical Care AG & Co. KGaA
Baxter International, Inc.
Boston Scientific Corp.
C.R. Bard, Inc.
Cook Group, Inc.
Hollister, Inc.
Nipro Corp.
Terumo Corp.
Coloplast A/S
ConvaTec Group plc
B. Braun AG
Teleflex, Inc.
Asahi Kasei Corp.
Nxstage Medical, Inc.

Order a free sample PDF of the Nephrology And Urology Devices Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Next-Generation Sequencing Data Analysis Market Size Is Expected To Reach USD 1.72 Billion By 2028

Next-generation Sequencing Data Analysis Industry Overview

The global next-generation sequencing data analysis market size was valued at USD 561.6 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 15.02% from 2021 to 2028. Next-generation sequencing (NGS) has effectively helped in studying epigenomic as well as genomic patterns associated with various biological processes. However, issues pertaining to storage, management, and accessing information are expected to provide the market with potential R&D opportunities, consequently fueling the growth of the market. Research communities that use high-throughput sequencers demand Laboratory Information Management Systems (LIMSs) for handling and archiving sequencing information. Cloud-based platforms offer favorable solutions for computationally intensive tasks during the analysis of NGS data. Therefore, it has become a quick and easy approach for the acquisition of computational resources to conduct NGS data analysis at a large scale.

The development of cloud-based bioinformatics platforms and services for large-scale NGS data analysis is expected to drive the market at a fast pace. BaseSpace, Bina, DNAnexus, LifeScope, GeneSifter, and SevenBridges are some of the commercially available cloud-based NGS tools readily adopted by end-users to analyze sequencing information.

Gather more insights about the market drivers, restrains and growth of the Global Next-generation Sequencing Data Analysis market

The incorporation of NGS protocols has been specifically used for oncology precision medicine, especially for lung and breast cancers. Companies are also focused on developing low-cost genome sequencing solutions to enhance their businesses. For instance, in October 2021, Phase Genomics announced to launch a cost-effective platform for genome analysis.

Similarly, various stakeholders in the industry are looking for companies that offer low-cost solutions. For instance, Gencoveraised USD 10 million to meet the demand for interpretable and accessible whole-genome sequencing. The company manages the cost by integrating low-pass whole-genome sequencing with a proprietary software-as-a-service computation.

The spontaneous spread of COVID-19 led to the increased emphasis on genome surveillance. Moreover, enhanced capabilities of genome surveillance can support the development of intelligent systems to track virus mutations and variants associated with respiratory conditions. In June 2021, the European Centre for Disease Prevention and Control announced the launch of EpiPulse, a European surveillance portal, for infectious diseases to gather, analyze, and share sequencing data associated with infectious diseases.

Furthermore, the companies are engaged in the deployment of such surveillance platforms, which can provide a robust platform for sequencing and analysis of viruses. For instance, in March 2021, Applied DNA Sciences, Inc. announced the launch of the Linea Genomic Surveillance Mutation Panel for COVID-19 to consolidate the process associated with SARS-CoV-2 variant tracking and detection.

Rising awareness and adoption of such genome surveillance platforms can play a powerful role in handling future health emergencies. In addition, the growth of such platforms is expected to create a lucrative growth opportunity for next-generation sequencing data analysis platforms in the coming years.

Browse through Grand View Research’s Biotechnology Industry Research Reports.

Genotyping Market – The global genotyping market was valued at USD 12.65 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 15.6% from 2022 to 2030. The growth can be attributed to technological advancements, the rising prevalence of cancer & genetic disorders, and increasing R&D funding for precision medicine research. Furthermore, the COVID-19 pandemic witnessed a positive impact on the genotyping market, as the pandemic led to an increased demand for COVID-19 genotyping kits. SNP genotyping has been used for the detection of genetic variants of the Covid-19 virus.

Viral Vectors And Plasmid DNA Manufacturing Market – The global viral vectors and plasmid DNA manufacturing market size was valued at USD 2.87 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 14.71% from 2022 to 2030. Viral vectors are tools for delivering genetic material into cells. Viruses have developed specific systems for transporting their DNA inside the cells they infect. Furthermore, retrovirus, adenovirus, lentivirus, herpes simplex virus, and others are among the viral vectors which can be employed to transfer genetic material into the genetic composition of cells.

Next-generation Sequencing Data Analysis Market Segmentation

Grand View Research has segmented the global next-generation sequencing data analysis market on the basis of product, workflow, mode, read length, end-use, and region:

Next-generation Sequencing Data Analysis Product Outlook (Revenue, USD Million, 2017 – 2028)

Services
NGS Commercial Software

Next-generation Sequencing Data Analysis Workflow Outlook (Revenue, USD Million, 2017 – 2028)

Primary
Secondary
Tertiary

Next-generation Sequencing Data Analysis Mode Outlook (Revenue, USD Million, 2017 – 2028)

In-house
Outsourced

Next-generation Sequencing Data Analysis Read Length Outlook (Revenue, USD Million, 2017 – 2028)

Short Read
Long Read
Very Long Read

Next-generation Sequencing Data Analysis End-use Outlook (Revenue, USD Million, 2017 – 2028)

Academic Research
Clinical Research
Hospitals & Clinics
Pharma& Biotech Entities
Other Users

Next-generation Sequencing Data Analysis Regional Outlook (Revenue, USD Million, 2017 – 2028)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

October 2021: Bionano Genomics, Inc. acquired BioDiscovery, Inc., a software company with the analysis, interpretation, and reporting of genomic data solutions. This acquisition allowed the company to improve its capabilities to analyze and interpret sequencing data.

Key Companies profiled:

Some prominent players in the global Next-generation Sequencing Data Analysis market include

Thermo Fisher Scientific, Inc.
QIAGEN
Illumina, Inc.
F. Hoffmann-La Roche Ltd.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
PierianDx
Precigen Bioinformatics Germany GmbH
Partek Incorporated
Eurofins Scientific
Pacific Biosciences of California, Inc.
DNASTAR, Inc.
Congenica Ltd.
Fabric Genomics, Inc.
Genuity Science
DNAnexus Inc.
SciGenom Labs Pvt. Ltd.
Golden Helix, Inc.
Verily Life Science

Order a free sample PDF of the Next-generation Sequencing Data Analysis Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Cosmetic Dentistry Market Size Is Expected To Reach USD 27.4 Billion By 2028

Cosmetic Dentistry Industry Overview

The global cosmetic dentistry market size was valued at USD 6.9 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.0% from 2021 to 2028. With an increase in the population opting for the improvement of dental aesthetics, this industry has undergone great advancements. Cognizance among the population about such techniques and procedures has allowed this industry to prosper by leaps and bounds. Developing countries have generated a large amount of disposable income, which is the main reason why cosmetic dentistry is flourishing. The geriatric population, in general, has propagated the growth of this industry with old age-related tooth ailments. Treatments that include teeth whitening, changes in dental appearance, and malocclusion are the most frequent procedures that patients undergo in cosmetic dentistry. Dental tourism has been an important reason that has caused cosmetic dentistry to prosper globally.

The major restraints in this market include the lack of reimbursement options for cosmetic procedures and the expensive cost of dental imaging. Insurance companies and government agencies do not regard cosmetic procedures as essential, and thus not many reimbursement options are available for cosmetic dentistry. On the other hand, dental imaging requires high technological equipment to be used requiring a large amount of money that is not covered by insurance companies, thereby proving to be another reason that hinders the growth of this market.

Gather more insights about the market drivers, restrains and growth of the Global Cosmetic Dentistry market

Based on product, dental systems and equipment held the largest market share in 2020 as they include a wide range of products that are used in a majority of the dental procedures involved. With an escalation in individuals opting for cosmetic dentistry, increasing orthodontic braces are also used extensively to alter dental disfigurations. With CAD and CAM systems, the designing of dental prosthetics has become relatively easy, allowing 3D technology to be used extensively, resulting in the accuracy of procedures.

Dental services were among the worst affected services at the beginning of the COVID-19 pandemic. Dental practices across the world were halted. With no patient visits and declining revenues, several dental surgeons had to undergo unforeseen challenges. However, telemedicine became a boon for both dental surgeons and patients. The technology, according to some cosmetic dentists, is here to stay in the long run. With the ease of lockdowns in most the countries, dental services are also reopening, however, following strict protocols has added to the expenses for several cosmetic dentists.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

MRI Contrast Media Agents Market – MRI contrast media agents are widely used to identify the presence of tumors, aneurysms, and other abnormalities in the tissues. In 1981, the first MRI contrast agent, ferric chloride was used to identify abnormalities in the GI tract. Later gadolinium compound was identified and is said to be the gold standard of MRI contrast media. Newer agents are constantly being identified and investigated. The extremely stringent guideline is laid for the clinical use of such agents, which makes their use perilous. Each contrast agent follows a unique route of administration, right from the intravenous route to oral administration.
Pen Needles Market – The global pen needles market size was valued at USD 2.7 billion in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 12.1% from 2022 to 2030. The growing prevalence of diabetes has led to the rising demand for pen needles. According to the International Diabetes Federation (IDF), 642 million people are estimated to have diabetes by 2040. With the rising diabetic population, the target market is expected to grow continuously during the forecast period.

Cosmetic Dentistry Market Segmentation

Grand View Research has segmented the global Cosmetic Dentistry market on the basis of product, end-use, and region:

Cosmetic Dentistry Product Outlook (Revenue, USD Million, 2016 – 2028)

Dental Systems & Equipment
- Instrument Delivery Systems
- Dental Chairs
- Dental Handpieces
- Light Curing Equipment
- Dental Scaling Units
- Dental CAM/CAD Systems
- Dental Lasers
- Dental Radiology Equipment
Dental Implants
Dental Crowns & Bridges
Dental Veneer
Orthodontic Braces
Bonding Agents
Inlays & Onlays
Whitening

Cosmetic Dentistry Regional Outlook (Revenue, USD Million, 2016 – 2028)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

March 2019: Align Technology, Inc. announced a distribution agreement for iTero Element Intraoral Scanners with Benco Dental, which is the largest privately-owned dental distributor in the U.S. The company’s iTero Element scanner can help dentists perform a wide range of restorative and orthodontic procedures with greater precision and visualization capabilities.

Key Companies profiled:

Some prominent players in the global Cosmetic Dentistry market include

Danaher Corporation
Align Technology Inc.
Dentsply International, Inc.
3M Company
Zimmer Biomet Holding, Inc.
Institut Straumann AG
Sirona Dental Systems, Inc.
Biolase, Inc.
Planmeca Oy
A-dec Inc.

Order a free sample PDF of the Cosmetic Dentistry Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Single-Cell Analysis Market Is Expected To Expand At A CAGR Of 15.0% From 2021 To 2028

Single-cell Analysis Industry Overview

The global single-cell analysis market size was valued at USD 2.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 15.0% from 2021 to 2028. An increase in investments and government funds deployed for research and development (R&D) in the field of medical diagnostics, availability of technically advanced products, and the rising adoption of single-cell analysis devices are some factors that can be attributed to the growth of the market.

Moreover, the advent of technology in single-cell amplification and manipulation techniques has led to the application of high throughput technologies in assays, thereby propelling revenue growth. In addition, the rapid development of microfluidic devices has significantly broadened the implementation of single-cell genomic/transcriptomic analysis in the biomedical field.

Gather more insights about the market drivers, restrains and growth of the Global Single-cell Analysis market

Technological advancements in sequencing techniques are transforming the landscape of single-cell omics research activities, including transcriptomic, epigenomics, and genomics. Significant advancements in sequencing reproducibility coupled with declining costs have helped process a large number of samples.

Increasing demand for analytical tools and technological advancements has led to the introduction of high-throughput machinery in the market. Several innovations have led to the introduction of new features such as high sensitivity, accuracy, and efficacy by utilizing scarce samples. Thus, key players are investing a significant amount in the development of solutions leading to a lucrative opportunity for revenue generation in the near future.

The ongoing pandemic of COVID-19 has triggered the adoption of single-cell analysis methods in virology research. The researchers are using these techniques to understand the immune profiles of infected patients. For instance, in a study published in January 2021, researchers from China performed high-dimensional single-cell analysis to understand the peripheral immune response to the COVID-19 infection.

Browse through Grand View Research’s Biotechnology Industry Research Reports.

3D Printed Drugs Market – The global 3D printed drugs market size was valued at USD 72.02 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 15.32% from 2022 to 2030. 3D printed drugs are prescriptions that are created using the 3D printing process to give individuals safe and effective tailored medications. These medications have a unitary porous architecture that disperses easily in the mouth, eliminating the need to swallow high-dose medications whole. It allows manufacturers to modify the size, look, form, and rate of distribution of a wide range of drugs with ease.
Immunoprotein Diagnostic Testing Market – The global immunoprotein diagnostic testing market size to be valued at USD 10.3 billion by 2025 and is expected to grow at a compound annual growth rate (CAGR) of 6.7% during the forecast period. Increase in prevalence of chronic diseases has led to growth of market. High prevalence of chronic disorders, such as infectious diseases, cancer, cardiovascular disease, obesity, type 2 diabetes, and rheumatoid arthritis has led to growth of immunoprotein diagnostic testing products.

Single-cell Analysis Market Segmentation

Grand View Research has segmented the global single-cell analysis market on the basis of product, application, workflow, end-use, and region:

Single Cell Analysis Product Outlook (Revenue, USD Million, 2017 – 2028)

Consumables
- Reagents
- Assay Kits
Instruments
- Microscope
- Hemocytometers
- Flow Cytometers
- NGS Systems
- PCR
- High Content Screening Systems
- Cell Microarrays
- Single Live Cell Imaging
- Automated Cell Counters

Single Cell Analysis Application Outlook (Revenue, USD Million, 2017 – 2028)

Cancer
Immunology
Neurology
Stem cell
Non-invasive prenatal diagnosis
In-vitro fertilization
Others

Single Cell Analysis Workflow Outlook (Revenue, USD Million, 2017 – 2028)

Single-cell isolation & Library Preparation
Downstream Analysis
Data Analysis

Single Cell Analysis End-use Outlook (Revenue, USD Million, 2017 – 2028)

Academic & Research Laboratories
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostic Laboratories
Others

Single Cell Analysis Regional Outlook (Revenue, USD Million, 2017 – 2028)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

February 2021: SeqWell Inc. launched plexWell Single Cell Rapid Kit for single-cell RNA sequencing. It is used for the simplified preparation of NGS libraries.
February 2021: for the commercialization of its products to expand its presence outside the U.S. Such company initiatives are expected to intensify market competition.

Key Companies profiled:

Some prominent players in the global Single-cell Analysis market include

Thermo Fisher Scientific Inc.
QIAGEN NV
Bio-Rad Laboratories Inc.
Illumina Inc.
Merck Millipore
Becton
Dickinson & Company
Fluidigm Corporation
10x Genomics, Inc.
BGI
Novogene Corporation

Order a free sample PDF of the Single-cell Analysis Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com